Toral Patel Selected Research

Pharyngitis (Sore Throat)

1/2017

Sensitivity for Diagnosing Group A Streptococcal Pharyngitis from Manufacturers is 10% Higher than Reported in Peer-Reviewed Publications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toral Patel Research Topics

Disease

3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2011
2	Neoplasms (Cancer) 01/2022 - 02/2011
2	Hemorrhage 01/2019 - 07/2013
1	Lymphoma (Lymphomas) 05/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Glioma (Gliomas) 01/2020
1	ST Elevation Myocardial Infarction 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Myocardial Infarction 01/2019
1	Cardiogenic Shock 01/2019
1	Stroke (Strokes) 01/2019
1	Pharyngitis (Sore Throat) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Hypertension (High Blood Pressure) 12/2016
1	Pneumonia (Pneumonitis) 06/2014
1	False Aneurysm (Pseudoaneurysm) 07/2013
1	Gliosarcoma 02/2011
1	Cerebrospinal Fluid Rhinorrhea 01/2010
1	Diarrhea 12/2009
1	Clostridium Infections 12/2009
1	Rheumatoid Arthritis 01/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2004

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	Large Neutral Amino Acid-Transporter 1IBA 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AcidsIBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2017
1	AntigensIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 12/2016
1	EDP 420IBA 06/2014
1	Indicators and Reagents (Reagents)IBA 07/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2011
1	PolymersIBA 02/2011
1	CamptothecinIBA 02/2011
1	Rifaximin (L 105)FDA Link 12/2009
1	Dexfenfluramine (Redux)IBA 12/2009
1	Vancomycin FDA LinkGeneric 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	CytokinesIBA 01/2004
1	Adalimumab (Humira)FDA Link 01/2004

Therapy/Procedure

4	Therapeutics 05/2022 - 01/2004
1	Transcatheter Aortic Valve Replacement 01/2019
1	General Anesthesia 01/2019
1	Decompression 01/2019
1	Extracorporeal Membrane Oxygenation 01/2019
1	Conscious Sedation 01/2019
1	Percutaneous Coronary Intervention 01/2019
1	Drug Therapy (Chemotherapy) 02/2011
1	Splints (Splint) 01/2010
1	Biological Therapy 01/2004
1	Subcutaneous Injections 01/2004